Clinical Development of CRISPR-Based Therapies in Oncology

Great strides have been made within pre-clinical research and discovery efforts that inform and enable an oncology development program based on CRISPR/Cas9 gene editing techniques, but there remains much to consider when it comes to implementing an early phase clinical trial.

Your form has been successfully submitted! Click the button below to access.


Read the first paper in this CRISPR series:
CRISPR, Gene-Based Therapeutics, and Clinical Trials 


CRISPR and the Commercialization of Gene-Based Therapies